SARS Pathogen Detection Resequencing Array

Epidemiologists can use the array to study how the virus is evolving over time, during its spread to different regions and populations.

One Custom Seq array can sequence about 30,000 bases of unique sequence quickly and with a high degree of accuracy, states Affymetrix, Inc. (Santa Clara, CA, USA), which developed the array. The array is based on the company's GeneChip platform and on sequences obtained from public health centers in Canada, the United States, and Asia.

"We hope that by getting this powerful CustomSeq array into the hands of scientists, we can contribute to understanding SARS and the search for treatments,” said Greg Yap, senior marketing director, DNA analysis, at Affymetrix.




Related Links:
Affymetrix